论文部分内容阅读
目的探讨分析CD41标记微小巨核细胞染色法在临床中的意义。方法景德镇市第三人民医院于2009年到2011年收治疑诊骨髓增生异常综合征的患者,对患者骨髓标本采用SP染色法进行检测。结果 CD41标记微小巨核细胞染色法结果显示,25例骨髓增生异常综合征患者全部为阳性,15例急性白血病患者中检出1例,20例再生障碍性贫血均显示为阴性。结论 CD41标记微小巨核细胞染色法在骨髓增生异常综合征的临床检出率较高,值得临床推广使用。
Objective To investigate the clinical significance of CD41-labeled micro-megakaryocyte staining. Methods The Third People’s Hospital of Jingdezhen City from 2009 to 2011, patients with suspected myelodysplastic syndrome were treated with SP staining of bone marrow specimens of patients. Results The results of microdisks staining by CD41 showed that all 25 cases of myelodysplastic syndrome were positive, 1 of 15 cases of acute leukemia and 20 cases of aplastic anemia were negative. Conclusion CD41 labeled micromegakaryocyte staining in myelodysplastic syndrome clinical detection rate is high, worthy of clinical promotion and use.